Estradiol oral - TherapeuticsMD

Drug Profile

Estradiol oral - TherapeuticsMD

Alternative Names: 17β-estradiol - TherapeuticsMD; TX 12-003HR; TX-003HR

Latest Information Update: 09 Jul 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator TherapeuticsMD
  • Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Vasomotor symptoms

Most Recent Events

  • 05 Mar 2014 Discontinued - Phase-I for Vasomotor symptoms in USA (PO)
  • 20 Aug 2013 Biomarkers information updated
  • 08 May 2013 Phase-I clinical trials in Vasomotor symptoms in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top